−838KRW
−31.42 BKRW
56.81 BKRW
29.89 M
About ICURE PHARM. INC.
Sector
CEO
Choi Young
Headquarters
Seoul
Website
Employees (FY)
280
Founded
2000
ISIN
KR7175250000
FIGI
BBG00L1561Q3
Icure Pharmaceutical Inc. engages in the development and manufacture of transdermal drug delivery system. It operates through the pharmaceutical and cosmeceutical business. The pharmaceutical business provides specialized and over-the-counter medical products such as anesthetic drugs, anticonvulsant, mixed vitamin pills, fever reducer, anti-inflammatory drugs, painkiller and others. The cosmeceutical business offers skin care, hair care and body products such as skin lotion, cream, cleanser, shampoo, hair essence, hand cream, mask and others. The company was founded on May 29, 2000 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 175250 is 1921 KRW — it has decreased by 1.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ICURE PHARM. INC. stocks are traded under the ticker 175250.
175250 stock is 1.25% volatile and has beta coefficient of 0.31. Check out the list of the most volatile stocks — is ICURE PHARM. INC. there?
Yes, you can track ICURE PHARM. INC. financials in yearly and quarterly reports right on TradingView.
175250 stock has risen by 0.58% compared to the previous week, the month change is a 2.29% rise, over the last year ICURE PHARM. INC. has showed a 45.89% decrease.
175250 net income for the last quarter is −16.48 B KRW, while the quarter before that showed −2.26 B KRW of net income which accounts for −630.72% change. Track more ICURE PHARM. INC. financial stats to get the full picture.
Today ICURE PHARM. INC. has the market capitalization of 71.45 B, it has decreased by 2.24% over the last week.
No, 175250 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 175250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ICURE PHARM. INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 280.00 employees. See our rating of the largest employees — is ICURE PHARM. INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ICURE PHARM. INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ICURE PHARM. INC. stock shows the sell signal. See more of ICURE PHARM. INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ICURE PHARM. INC. EBITDA is −18.76 B KRW, and current EBITDA margin is −32.89%. See more stats in ICURE PHARM. INC. financial statements.